Subramani et al. showed that SIRT6 silencing might represent a strategy for mitigating lung cancer progression; upon its knockdown DNMT1 is acetylated and stabilized, therefore promoting NOTCH1 promoter methylation, and thus repressing its expression [145]. Here, NOTCH1 is linked to lung carcinoma.